• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

INSIGHTEC

Insightec logs Medicare win for MR-guided focused ultrasound in treating essential tremor

July 9, 2018 By Sarah Faulkner

Insightec said today that it won Medicare benefit coverage for its MR-guided focused ultrasound system for the treatment of essential tremor in six new states, bringing the total number of states with Medicare coverage for its tech to 16. The company’s system will now be covered under Medicare in Indiana, Iowa, Kansas, Nebraska, Michigan and […]

Filed Under: Surgical, Ultrasound Tagged With: INSIGHTEC

Insightec wins Medicare coverage in 10 states

June 5, 2018 By Nancy Crotti

Insightec has won Medicare coverage for its magnetic technology that treats essential tremor via ultrasound. The Centers for Medicare and Medicaid Services have approved the company’s Exablate Neuro device for patients in 10 U.S. states and will add coverage for six more states July 1, according to a company statement. Additional Medicare administrative contractors have issued […]

Filed Under: Business/Financial News, Ultrasound Tagged With: INSIGHTEC

Insightec seeks Parkinson’s indication in Japan for Exablate Neuro

May 18, 2018 By Fink Densford

Insightec said this week it submitted an application for pre-market approval to the Japanese Pharmaceuticals and Medical Devices Agency seeking an indication for its Exablate Neuro to treat advanced Parkinson’s Disease in patients suffering from mobility, rigidity or dyskinesia. The Israel-based company’s Exablate Neuro device uses high-intensity, focused ultrasound to thermally ablate targeted tissue, guided by continuous […]

Filed Under: Neurological, Regulatory/Compliance, Ultrasound Tagged With: INSIGHTEC

Insightec closes $150m Series E

January 31, 2018 By Fink Densford

Insightec said today it closed a $150 million Series E private equity round of financing with plans to use funds to support marketing, commercialization and further development of its Exablate Neuro platform. The round was led by Koch Disruptive Technologies subsidiary Koch Industries, who invested a total of $100 million during the round, the Israel-based company […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: INSIGHTEC

Insightec, Virginia Tech collab on focused ultrasound brain disorder R&D

January 29, 2018 By Fink Densford

Insightec said today it is partnering with the Virginia Tech Carilion Research Institute looking to develop treatments for brain disorders utilizing the company’s Exablate Neuro focused ultrasound device. The treatments will also utilize Siemens (NYSE:SI) magnetic resonance imaging devices, with potential applications in treating cancer, brain tumors, targeted disruptions of the blood-brain barrier for therapeutic delivery and neuromodulation […]

Filed Under: Neurological, Research & Development, Ultrasound Tagged With: INSIGHTEC

Insightec raises $150m in Series E

December 15, 2017 By Fink Densford

Insightec said yesterday it raised $150 million in a Series E round of financing led by Koch Industries’ Koch Disruptive Technologies to support its MRI-guided focused ultrasound technologies. The round was led by Koch Disruptive Technologies and joined by existing investors Elbit Imaging, York Capital, Focus Holdings, GE Healthcare (NYSE:GE), GEOC and Meditech Advisors, the Israel-based company […]

Filed Under: Business/Financial News Tagged With: INSIGHTEC

Insightec wins FDA nod for Exablate Neuro glioblastoma trial

November 28, 2017 By Fink Densford

Insightec said today it won FDA approval to launch a safety and feasibility trial of its Exablate Neuro, testing its ability to disrupt the blood brain barrier in patients with glioblastoma. The Exablate Neuro device, which won FDA approval last July for treating essential tremor, uses high-intensity, focused ultrasound to thermally ablate targeted tissue, guided by […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Neurological Tagged With: INSIGHTEC

FDA approves pivotal trial for Insightec’s Exablate Neuro in Parkinson’s

October 25, 2017 By Brad Perriello

Insightec said today that it won FDA approval for a pivotal trial of its Exablate Neuro device in treating refractory Parkinson’s disease. Haifa, Israel-based Insightec said the the study will evaluate using Exablate Neuro’s MR-guided focused ultrasound to ablate portions of the globus pallidus in the brain, which helps regulate voluntary movement. The trial, led by […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Imaging, Radiosurgery/Radiation therapy Tagged With: INSIGHTEC

The 11 most innovative medical devices of 2017

October 19, 2017 By Danielle Kirsh

The nominees for the best medical technology of 2017 were recently announced for the 11th Annual Prix Galien USA Awards. The Galien Foundation, the host of the awards, hands out the the Prix Galien Award annually to examples of outstanding biomedical and technology product achievement designed to improve human condition. Before candidates can qualify for […]

Filed Under: Blood Management, Cardiac Implants, Cardiovascular, Catheters, Diagnostics, Hospital Care, Imaging, Implants, Mammography, Neurological, Patient Monitoring, Surgical, Wound Care Tagged With: Abbott, Allergan, Biosense Webster, Boston MedTech Advisors, Boston Scientific, BrainScope, depuysynthes, Ethicon, INSIGHTEC, Integra LifeSciences, Johnson and Johnson, Koning Corporation

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS